Citizens JMP raised the firm’s price target on American Healthcare REIT (AHR) to $50 from $45 and keeps an Outperform rating on the shares. American Healthcare REIT should continue to benefit from an extreme supply/demand imbalance across senior housing and the excellence of Trilogy’s operations, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AHR:
- American Healthcare REIT price target raised to $43 from $40 at KeyBanc
- American Healthcare REIT initiated with a Buy at UBS
- Buy Rating for American Healthcare REIT, Inc. Driven by Strong AFFO Growth and Strategic Expansion in Senior Housing
- American Healthcare REIT Announces Quarterly Distribution
- American Healthcare REIT price target raised to $48 from $45 at Morgan Stanley